Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter V Mental and behavioural disorders,F5_VASCDEM,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.88 [0.78-1],0.0531329618969998,trans
Chapter V Mental and behavioural disorders,F5_VASCDEM,NEFL,Neurofilament light polypeptide,Wald ratio,1,0.92 [0.81-1.05],0.205031583057211,trans
Chapter V Mental and behavioural disorders,F5_VASCDEM,EPHA2,Ephrin type-A receptor 2,Wald ratio,1,0.94 [0.81-1.08],0.387537261816106,trans
Chapter V Mental and behavioural disorders,F5_VASCDEM,WFDC2,WAP four-disulfide core domain protein 2,Wald ratio,1,0.95 [0.83-1.09],0.469415907073079,trans
Chapter V Mental and behavioural disorders,F5_VASCDEM,LGALS4,Galectin-4,Wald ratio,1,0.95 [0.83-1.09],0.469916688710996,trans
Chapter V Mental and behavioural disorders,F5_VASCDEM,CHGA,Chromogranin-A,Wald ratio,1,0.96 [0.83-1.11],0.593409139586129,trans
Chapter V Mental and behavioural disorders,F5_VASCDEM,VSIG2,V-set and immunoglobulin domain-containing protein 2,Wald ratio,1,1.04 [0.9-1.2],0.622770248636691,trans
Chapter V Mental and behavioural disorders,F5_VASCDEM,GFAP,Glial fibrillary acidic protein,Wald ratio,1,0.97 [0.84-1.11],0.638823166078267,trans
